BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29723590)

  • 21. Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
    Jauw YW; Zijlstra JM; de Jong D; Vugts DJ; Zweegman S; Hoekstra OS; van Dongen GA; Huisman MC
    PLoS One; 2017; 12(1):e0169828. PubMed ID: 28060891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype.
    Montes-Moreno S; Gonzalez-Medina AR; Rodriguez-Pinilla SM; Maestre L; Sanchez-Verde L; Roncador G; Mollejo M; García JF; Menarguez J; Montalbán C; Ruiz-Marcellan MC; Conde E; Piris MA
    Haematologica; 2010 Aug; 95(8):1342-9. PubMed ID: 20418245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nodal versus extranodal diffuse large B-cell lymphoma: comparison of clinicopathologic features, immunophenotype and prognosis].
    Lu JB; Li XQ; Zhang PH; Zhou XY; Zhang TM; Li XM; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):470-3. PubMed ID: 17845761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary Nodal Unclassifiable CD20 Negative Diffuse Large B-cell Lymphoma With Dual
    Hadžisejdić I; Klarica L; Babarović E; Marijić B; Valković T; Jonjić N
    Clin Pathol; 2023; 16():2632010X221149978. PubMed ID: 36684058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach.
    de Jong MRW; Visser L; Huls G; Diepstra A; van Vugt M; Ammatuna E; van Rijn RS; Vellenga E; van den Berg A; Fehrmann RSN; van Meerten T
    PLoS One; 2018; 13(2):e0193098. PubMed ID: 29489886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature.
    Alvaro-Naranjo T; Jaén-Martínez J; Gumá-Padró J; Bosch-Príncep R; Salvadó-Usach MT
    Ann Hematol; 2003 Sep; 82(9):585-8. PubMed ID: 12898184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CD20-negative diffuse large B-cell lymphoma complicated by rheumatoid arthritis].
    Yoshino T; Makiyama J; Imaizumi Y; Matsuo E; Kitanosono H; Nakashima J; Kato T; Miyoshi H; Ohshima K; Yoshida S; Miyazaki Y
    Rinsho Ketsueki; 2020; 61(1):33-38. PubMed ID: 32023600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics.
    Booman M; Douwes J; Glas AM; de Jong D; Schuuring E; Kluin PM
    J Pathol; 2006 Oct; 210(2):163-71. PubMed ID: 16823896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of B cell-specific activator protein in lymphomas].
    Li D; Li GD; Liu WP; Li FY; Zhang WY; Liao DY
    Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):345-7. PubMed ID: 16185503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggressive primary testicular diffuse large B-cell lymphoma, not otherwise specified with expression of interferon-γ and its receptors.
    Nakayama-Ichiyama S; Yokote T; Hirata Y; Iwaki K; Nishiwaki U; Miyoshi T; Masuda Y; Akioka T; Tsuji M; Hanafusa T
    Acta Oncol; 2012 Jul; 51(6):814-6. PubMed ID: 22283493
    [No Abstract]   [Full Text] [Related]  

  • 32. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
    Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
    Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotype profiling of primary testicular diffuse large B-cell lymphomas.
    Menter T; Ernst M; Drachneris J; Dirnhofer S; Barghorn A; Went P; Tzankov A
    Hematol Oncol; 2014 Jun; 32(2):72-81. PubMed ID: 23949965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma.
    Hatzl S; Posch F; Schulz E; Gornicec M; Deutsch A; Beham-Schmid C; Pichler M; Greinix H; Sill H; Zebisch A; Neumeister P; Prochazka KT
    Pathol Oncol Res; 2020 Oct; 26(4):2831-2833. PubMed ID: 32602002
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary testicular lymphoma and AIDS.
    Verma N; Chaudhary UB; Costa LJ; Gudena V; Lazarchick J
    Ann Clin Lab Sci; 2010; 40(1):75-9. PubMed ID: 20124334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extranodal CD20-positive peripheral T-cell lymphoma presenting with adrenal and testicular masses.
    Makita M; Murakami I; Yoshioka T; Tanaka H; Yamamoto K; Imajo K; Takata K; Yoshino T
    Rinsho Ketsueki; 2009 May; 50(5):413-8. PubMed ID: 19483402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testis-Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular and Systemic DLBCL and Correlate with Clinical Disease Presentation.
    Chan MC; Savela J; Ollikainen RK; Teppo HR; Miinalainen I; Pirinen R; Kari EJM; Kuitunen H; Turpeenniemi-Hujanen T; Kuittinen O; Kuusisto MEL
    Oxid Med Cell Longev; 2021; 2021():8026941. PubMed ID: 33603952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic features of B-Cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases.
    Oliveira JL; Grogg KL; Macon WR; Dogan A; Feldman AL
    Am J Surg Pathol; 2012 Sep; 36(9):1364-70. PubMed ID: 22895269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary splenic diffuse large B-cell lymphoma manifesting in red pulp.
    Kashimura M; Noro M; Akikusa B; Okuhara A; Momose S; Miura I; Kojima M; Tamaru J
    Virchows Arch; 2008 Nov; 453(5):501-9. PubMed ID: 18818942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary testicular presentation of ALK-1-negative anaplastic large cell lymphoma in a pediatric patient.
    Lagmay J; Termuhlen A; Fung B; Ranalli M
    J Pediatr Hematol Oncol; 2009 May; 31(5):330-2. PubMed ID: 19415011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.